布雷克西普拉与塞特拉林结合使用,以及作为创伤后应激障碍的单疗法:一个全因子随机临床试验
Mary Hobart1,2, Denise Chang1, Nanco Hefting3
1Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey.
The Journal of clinical psychiatry
|February 26, 2025
概括
与单独使用塞特拉林相比,与塞特拉林结合的布雷克西普拉可显著改善创伤后应激障碍 (PTSD) 症状. 这种组合疗法显示出作为一种有效的PTSD治疗的潜力,具有可管理的安全性.
科学领域:
- 精神病学和行为科学
- 临床药理学 临床药理学
- 神经科学是一个神经科学.
背景情况:
- 创伤后应激障碍 (PTSD) 是一种使人虚弱的疾病,通常需要多方面的治疗方法.
- 目前对PTSD的药物治疗有局限性,需要探索新的治疗策略.
- 布雷克西普拉和塞特拉林是已知的药物,具有与PTSD病理生理学相关的独特作用机制.
研究的目的:
- 评估布雷克斯皮普拉与塞特拉林联合治疗PTSD的疗效和安全性.
- 为了比较组合治疗与单一治疗,使用任何药物和安慰剂.
- 评估布雷克斯皮普拉和塞特拉林联合治疗在患有PTSD的成人门诊患者的耐受性.
主要方法:
- 一个随机,双盲,安慰剂对照试验,涉及诊断患有PTSD (DSM-5) 的成年门诊患者.
- 参与者被分配到四个手臂之一:布雷克斯皮普拉佐尔+塞特拉林,布雷克斯皮普拉佐尔+安慰剂,塞特拉林+安慰剂,或安慰剂+安慰剂.
- 主要疗效终点是从基线到第10周的DSM-5 (CAPS-5) 临床医生管理的PTSD尺度总得分的变化.
主要成果:
- 与塞特拉林单独治疗相比,布雷克斯皮普拉和塞特拉林的组合表明,CAPS-5得分在统计学上显著地得到了更大的改善 (P=.011).
- 对于联合治疗与布雷克斯皮普拉单一治疗和安慰剂单一治疗相比,也观察到显著的改善.
- 这种组合的常见治疗出现的不良事件包括体重增加和昏昏欲睡;单独治疗塞特拉林的恶心和口腔干燥率更高.
结论:
- 布雷克西普拉与塞特拉林结合,代表了对PTSD的有希望的新疗法选择.
- 在这项试验中,单独使用布雷克斯皮普拉或塞特拉林的疗法与安慰剂没有显著的疗效.
- 组合治疗的安全性概况与布雷克斯皮普拉和塞特拉林已知的副作用一致.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
176
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
176
Post-traumatic Stress Disorder
27
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
27
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
274
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
274
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22


